Preferentially released miR-122 from cyclodextrin-based star copolymer nanoparticle enhances hepatoma chemotherapy by apoptosis induction and cytotoxics efflux inhibition
Author:
Funder
National Major Science and Technology Projects of China
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Biomedical Engineering,Biomaterials,Biotechnology
Reference36 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA;Bray;A Cancer Journal for Clinicians,2018
2. Hepatocellular carcinoma;Forner;Lancet,2018
3. Recent developments and therapeutic strategies against hepatocellular carcinoma;Yarchoan;Canc. Res.,2019
4. Sorafenib in advanced hepatocellular carcinoma;Llovet;N. Engl. J. Med.,2008
5. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial;Bruix;Lancet,2017
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Predicting anti-tumor efficacy of multi-functional nanomedicine on decellularized hepatocellular carcinoma-on-a-chip;Biosensors and Bioelectronics;2024-11
2. Application of Nanoparticles in the Diagnosis and Treatment of Colorectal Cancer;Anti-Cancer Agents in Medicinal Chemistry;2024-11
3. Inhibitory Effects of Royal Jelly and Its Functional Components on the Proliferation of MKN-28 Gastric Cancer Cells;Journal of Agricultural and Food Chemistry;2024-09-12
4. Enhanced chemotherapy response in hepatocellular carcinoma: synergistic effects of miR-122 and doxorubicin co-delivery system inducing apoptosis and DNA damage;Cancer Nanotechnology;2024-08-28
5. A fully biodegradable spherical nucleic acid nanoplatform for self-codelivery of doxorubicin and miR122 for innate and adaptive immunity activation;Acta Biomaterialia;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3